Andrea Ranzoni

Andrea has been working in the field of medical technologies for more than a decade after obtaining a MSc degree in Physical Engineering (Polytechnic of Milan) and a MSc in Electronic Engineering (Polytechnic of Turin). After relocating to The Netherlands and joining Philips Research, Andrea became part of the team that developed the Magnotech platform, commercialised as Minicare I-20 for detection of cardiac troponin at the point-of-care. Andrea was awarded a PhD in Applied Physics from Eindhoven University of Technology for his work on opto-magnetic nanotechnologies for biomarker detection in complex fluids.

As Head of Bioengineering at Ellume (Brisbane), Andrea’s responsibilities encompassed the invention and transfer to mass-production of a novel biofunctional fluorescent nanoparticle with engineered surface properties for minimal non-specific interactions. In parallel, he led cross-functional teams and worked across multiple projects, from early feasibility to regulatory clearance and manufacturing of diagnostic tests, software applications and handheld smartphone-like devices. As Head of Commercialisation at The iQ Group Global (Sydney), Andrea’s accountabilities encompassed establishing a novel business unit aiming to transfer to manufacture and achieve regulatory approval for a digital biosensor capable of detecting glucose from a saliva sample. The role required definition of a global commercialisation and go-to-market strategy, the on boarding of a cross-functional team (engineering, software development, quality assurance, regulatory affairs, marketing, production, project management, medical affairs) and to create business processes to support operations

"The ultimate test of your knowledge is your capacity to convey it to another." - Richard P. Feynman